Cargando…
Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition
Epithelial–mesenchymal transition (EMT) is thought to contribute to the progression of renal tubulointerstitial fibrosis. Norcantharidin (NCTD) is a promising agent for inhibiting renal interstitial fibrosis. However, the molecular mechanisms of NCTD are unclear. In this study, a unilateral ureteral...
Autores principales: | Li, Ying, Sun, Yan, Liu, Fuyou, Sun, Lin, Li, Jun, Duan, Shaobin, Liu, Hong, Peng, Youming, Xiao, Li, Liu, Yuping, Xi, Yiyun, You, Yanhua, Li, Hua, Wang, Min, Wang, Shuai, Hou, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692527/ https://www.ncbi.nlm.nih.gov/pubmed/23825538 http://dx.doi.org/10.1371/journal.pone.0066356 |
Ejemplares similares
-
Correction: Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition
por: Li, Ying, et al.
Publicado: (2013) -
Tubular atrophy/interstitial fibrosis scores of Oxford classification combinded with proteinuria level at biopsy provides earlier risk prediction in lgA nephropathy
por: Zhu, Xuejing, et al.
Publicado: (2017) -
Rapamycin Ameliorates Kidney Fibrosis by Inhibiting the Activation of mTOR Signaling in Interstitial Macrophages and Myofibroblasts
por: Chen, Guochun, et al.
Publicado: (2012) -
Hesperetin alleviates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro
por: Wang, Hong-Wei, et al.
Publicado: (2017) -
Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin
por: Liu, Qian, et al.
Publicado: (2022)